BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Biotech Beach

  13-Employee SoCal Startup Bioniz Has A $400 Million Valuation

  Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics.

  December 20, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Bay Area Align Tech Terminates Interoperability Pact With 3Shape

  Last month Align Tech filed formal patent infringement complaints against medical device maker 3Shape.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Visioneering Technologies Welcomes Senior Life Sciences Executive Jean Franchi to its Board of Directors

  VTI is pleased to announce the appointment of Ms. Jean Franchi to its Board of Directors, and as Chair of the Audit and Risk Committee.

  December 20, 2017

   · 

  1 min read
• 

  Orchard Therapeutics Scoops Up $110M in Funding to Advance “Bubble Boy Syndrome” Gene Therapy

  Baillie Gifford and ORI Capital co-led the financing with significant new investments from Temasek and Cowen Healthcare Investments, alongside Juda Capital, Pavilion Capital, RTW Investments, Agent Capital, 4BIO Capital and existing investors F-Prime Capital and UCL Technology Fund.

  December 20, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Completion of Akorn Takeover Expected in Early 2018

  Fresenius now expects its planned takeover of Akorn, a U.S. maker of liquid generic drugs, to be completed in early 2018 rather than this year, a spokesman for Fresenius said on Tuesday.

  December 20, 2017

   · 

  1 min read
• 

  Deals

  Takeover Whispers Boost Shire, Mega Deal to Bring Shareholders an Early Christmas Present

  Takeover whispers boosted long-standing target Shire to the top of the FTSE 100 as the pharma firm’s shares rallied on hopes of a mega deal bringing shareholders an early Christmas present.

  December 20, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  JSR Life Sciences Snaps Up CRO in $400M Deal

  The parent company of JSR Life Sciences snapped up CRO Crown Bioscience International for $400M, the company announced this morning.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Indiana’s Richest Person is Medical Device Billionaire Carl Cook

  For over 50 years, Cook Group’s catheters, filters and stents have helped patients get healthy, and proceeds from their sales make up the bulk of heir and CEO Carl Cook’s fortune.

  December 20, 2017

   · 

  1 min read
• 

  Drug Development

  AbbVie Scores Key Trial Win for RA Drug With One Fatal Event Reported

  AbbVie’s investigational JAK1-inhibitor upadacitinib yielded positive top-line results in a Phase III trial as a monotherapy for rheumatoid arthritis patients.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  Why This Little Known Biotech Is Pharma’s New Poster Child for Price Gouging

  Another lawmaker is taking on a pharmaceutical company for drug pricing.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown